Select any link to see items in a related category.
more general categories information about this item C04. Neoplasms C04. Neoplasms Neoplasms [MESH:D009369] (10293) Neoplasms by Site [MESH:D009371] (9169) Endocrine Gland Neoplasms [MESH:D004701] (4925) Pituitary Neoplasms [MESH:D010911] (981) Nervous System Neoplasms [MESH:D009423] (3130) Central Nervous System Neoplasms [MESH:D016543] (3055) Brain Neoplasms [MESH:D001932] (2764) Supratentorial Neoplasms [MESH:D015173] (930) Hypothalamic Neoplasms [MESH:D007029] (922) Pituitary Neoplasms [MESH:D010911] (914) C10. Nervous System Diseases C10. Nervous System Diseases Nervous System Diseases [MESH:D009422] (13325) Central Nervous System Diseases [MESH:D002493] (9745) Brain Diseases [MESH:D001927] (9294) Basal Ganglia Diseases [MESH:D001480] (4268) Parkinsonian Disorders [MESH:D020734] (4009) Parkinson Disease [MESH:D010300] (3595) Brain Neoplasms [MESH:D001932] (2764) Supratentorial Neoplasms [MESH:D015173] (930) Hypothalamic Neoplasms [MESH:D007029] (922) Pituitary Neoplasms [MESH:D010911] (914) Epilepsy [MESH:D004827] (6274) Seizures [MESH:D012640] (4502) Hypothalamic Diseases [MESH:D007027] (1833) Hypothalamic Neoplasms [MESH:D007029] (922) Pituitary Neoplasms [MESH:D010911] (914) Pituitary Diseases [MESH:D010900] (1808) Pituitary Neoplasms [MESH:D010911] (981) Hyperpituitarism [MESH:D006964] (1250) Hyperprolactinemia [MESH:D006966] (603) Movement Disorders [MESH:D009069] (4823) Dyskinesias [MESH:D020820] (1827) Dyskinesia, Drug-Induced [MESH:D004409] (1389) Dystonic Disorders [MESH:D020821] (729) Myoclonic dystonia [MESH:C536096] (245) Parkinsonian Disorders [MESH:D020734] (4009) Parkinson Disease [MESH:D010300] (3595) Nervous System Neoplasms [MESH:D009423] (3073) Central Nervous System Neoplasms [MESH:D016543] (3055) Brain Neoplasms [MESH:D001932] (2764) Supratentorial Neoplasms [MESH:D015173] (930) Hypothalamic Neoplasms [MESH:D007029] (922) Pituitary Neoplasms [MESH:D010911] (914) Neurodegenerative Diseases [MESH:D019636] (6613) Parkinson Disease [MESH:D010300] (3595) Neurologic Manifestations [MESH:D009461] (8964) Pain [MESH:D010146] (3875) Seizures [MESH:D012640] (4514) Dyskinesias [MESH:D020820] (3365) Catalepsy [MESH:D002375] (1429) Hyperkinesis [MESH:D006948] (1799) Neurotoxicity Syndromes [MESH:D020258] (4570) Dyskinesia, Drug-Induced [MESH:D004409] (1389) C14. Cardiovascular Diseases C14. Cardiovascular Diseases Cardiovascular Diseases [MESH:D002318] (10123) Heart Diseases [MESH:D006331] (8614) Arrhythmias, Cardiac [MESH:D001145] (4679) Bradycardia [MESH:D001919] (1899) Tachycardia [MESH:D013610] (3339) Vascular Diseases [MESH:D014652] (8691) Hypertension [MESH:D006973] (5655) Hypotension [MESH:D007022] (4045) C19. Endocrine System Diseases C19. Endocrine System Diseases Endocrine System Diseases [MESH:D004700] (8062) Endocrine Gland Neoplasms [MESH:D004701] (4925) Pituitary Neoplasms [MESH:D010911] (981) Pituitary Diseases [MESH:D010900] (1829) Pituitary Neoplasms [MESH:D010911] (981) Hyperpituitarism [MESH:D006964] (1259) Hyperprolactinemia [MESH:D006966] (603) C23. Pathological Conditions, Signs and Symptoms C23. Pathological Conditions, Signs and Symptoms Pathologic Processes [MESH:D010335] (9863) Arrhythmias, Cardiac [MESH:D001145] (4658) Bradycardia [MESH:D001919] (1899) Tachycardia [MESH:D013610] (3339) Signs and Symptoms [MESH:D012816] (10659) Pain [MESH:D010146] (4511) Body Weight [MESH:D001835] (4972) Body Weight Changes [MESH:D001836] (3206) Weight Gain [MESH:D015430] (2595) Neurologic Manifestations [MESH:D009461] (8702) Pain [MESH:D010146] (3869) Seizures [MESH:D012640] (4502) Dyskinesias [MESH:D020820] (3285) Catalepsy [MESH:D002375] (1429) Hyperkinesis [MESH:D006948] (1799) C25. Chemically-Induced Disorders C25. Chemically-Induced Disorders Drug-Related Side Effects and Adverse Reactions [MESH:D064420] (5839) Dyskinesia, Drug-Induced [MESH:D004409] (1389) Poisoning [MESH:D011041] (6703) Neurotoxicity Syndromes [MESH:D020258] (3323) Dyskinesia, Drug-Induced [MESH:D004409] (1389) Substance-Related Disorders [MESH:D019966] (6308) Amphetamine-Related Disorders [MESH:D019969] (2858) Cocaine-Related Disorders [MESH:D019970] (3054) Substance Withdrawal Syndrome [MESH:D013375] (2956) Tobacco Use Disorder [MESH:D014029] (628) Opioid-Related Disorders [MESH:D009293] (1491) Heroin Dependence [MESH:D006556] (950) D03. Heterocyclic Compounds D03. Heterocyclic Compounds Heterocyclic Compounds [MESH:D006571] (56330) Heterocyclic Compounds, 2-Ring [MESH:D006574] (24204) Quinolines [MESH:D011804] (2182) D27. Chemical Actions and Uses D27. Chemical Actions and Uses Pharmacologic Actions [MESH:D020228] (2566) Molecular Mechanisms of Pharmacological Action [MESH:D045504] (1155) Alkylating Agents [MESH:D000477] (15) Neurotransmitter Agents [MESH:D018377] (361) Adrenergic Agents [MESH:D018663] (73) Adrenergic Antagonists [MESH:D018674] (42) Adrenergic alpha-Antagonists [MESH:D000317] (25) Dopamine Agents [MESH:D015259] (34) Dopamine Antagonists [MESH:D018492] (12) Serotonin Agents [MESH:D018490] (61) Serotonin Antagonists [MESH:D012702] (28) Physiological Effects of Drugs [MESH:D045505] (1186) Neurotransmitter Agents [MESH:D018377] (353) Adrenergic Agents [MESH:D018663] (73) Adrenergic Antagonists [MESH:D018674] (42) Adrenergic alpha-Antagonists [MESH:D000317] (25) Dopamine Agents [MESH:D015259] (34) Dopamine Antagonists [MESH:D018492] (12) Serotonin Agents [MESH:D018490] (61) Serotonin Antagonists [MESH:D012702] (28) Toxic Actions [MESH:D004786] (206) Noxae [MESH:D009676] (136) Alkylating Agents [MESH:D000477] (15)
